Clinical Trials Logo
  1. Home
  2. Chronic Kidney Diseases
  3. NCT05168449
  4. Details
NCT05168449 Clinical Trial

The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients

Chronic Kidney Diseases Clinical Trial

Official title:
The Impact of Pharmacist - Led Mobile Application on Medication Adherence and Efficacy in Chronic Kidney Disease Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05168449
Other study ID # CL (2871)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 17, 2022
Est. completion date December 5, 2023

Study information
Verified date February 2024
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients

Description:

This is a prospective randomized two group pharmacist-led interventional study that will be conducted in a private nephrology clinic. The study will involve introduction of the mobile phone applications to chronic kidney disease patients to improve their adherence to the prescribed medications. Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured. Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months. The study will include the development, validation and the testing for evaluating the specially designed mobile application.

Recruitment information / eligibility
Status Completed
Enrollment 86
Est. completion date December 5, 2023
Est. primary completion date December 5, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Stages 2-5 of chronic kidney disease - Literate - Ownership of android smart phone compatible with the application - Poly-pharmacy Exclusion Criteria: - On dialysis due to loss of kidney function - Pregnancy due to altered physiology

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Mobile Application
mobile phone applications directed to chronic kidney disease patients to improve their medication.

Locations
Country Name City State
Egypt Private Clinic Cairo

Sponsors (1)
Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in medication adherence Using a medication adherence questionnaire. Change from baseline at 3 months
Secondary Change in estimated glomerular filtration rate/ creatinine clearance Calculated using serum creatinine lab results obtained from clinic. Change from baseline at 3 months
Secondary Change in systolic and diastolic blood pressure To be measured in clinic. Change from baseline at 3 months
Secondary Change in HbA1c Lab results obtained from clinic. Change from baseline at 3 months
Secondary Change in mobile application usability and acceptability by patients Using System Usability Scale (SUS) questionnaire. (scale 0-100 with higher score meaning better usability) Change from baseline at 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT06386172 - Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm N/A
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Terminated NCT05022329 - COVID-19 Vaccine Boosters in Patients With CKD Phase 2/Phase 3
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Recruiting NCT04961164 - Resistant Starch Prebiotic Effects in Chronic Kidney Disease N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT04363554 - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease N/A
Recruiting NCT04831021 - Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? N/A
Terminated NCT04877847 - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury N/A
Recruiting NCT04422652 - Combination of Novel Therapies for CKD Comorbid Depression Phase 2
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Not yet recruiting NCT06330480 - Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Terminated NCT02539680 - Intestinal Phosphate Transporter Expression in CKD Patients N/A